NEW DELHI, DEC 25
Aiming to make a healthy India, Prime Minister Narendra Modi on the eve of Good Governanc Day, Saturday announced that COVID vax for youth in the age group of 15 to 18 years will commence on January 3, 2022, Monday and preacaution dose for senior citizens or 60 years and above will commence on January 10, 2022, Monday.
My address to the nation. https://t.co/dBQKvHXPtv
— Narendra Modi (@narendramodi) December 25, 2021
As the nation witnesses spike of cases of the new Covid-19 variant ‘Omicron’, the Prime Minister addressed the country on Saturday and assured that India has 18 lakh isolation beds, 5 lakh oxygen supported beds, 1.40 lakh ICU beds, 90,000 pediatric ICU & non-ICU beds.
“We have more than 3,000 working PSA oxygen plants, 4 lakh oxygen cylinders have been distributed throughout the nation,” he said, adding that there is no need to panic.
India will soon have the nasal vaccine. From 3rd January, India will have a vaccine for kids aged 15-18, assured the PM.
He urged the citizens “This is time to be careful while engaging in festivities”
It is not time to panic, but we all must be careful; Use of masks, hand sanitization must be followed, he said.
He added that global experience shows following all preventive measures at a personal level is a big weapon to fight Covid. Nasal vaccine, the world’s first DNA vaccine against Covid will soon start in India. Over 90 pc of the eligible adult population got the first dose and over 61 pc have got both doses of Covid vaccine.
Covid vaccination for 15-18 years of children to start from January 3. Those with comorbidities and above 60 years of age on the recommendation of their doctors will be eligible for precaution doses from January 10, 2022 onwards.
In addition to this, PM Modi also revealed that healthcare and frontline workers will also be jabbed with the booster dose in order to curb the spread of the Omicron variant.
Covaxin gets DCGI nod for emergency use in children aged 12-18 years
COVAXIN® receives approval for emergency use in Children 12 – 18 years of age.#covaxin #COVID19 #covaxinapproval#childrensafety #BharatBiotech #vaccine #safety #pandemic pic.twitter.com/3LswUG8QU4
— Bharat Biotech (@BharatBiotech) December 25, 2021
Bharat Biotech on Saturday said it received DCGI approval for emergency use of Covaxin for children aged 12-18 years.
The vaccine has established a proven record for safety and efficacy in adults for the original variant and subsequent variants.
“We have documented excellent safety and immunogenicity data readouts in children. We look forward for Covaxin to provide similar levels of protection for adults and children alike, ” Bharat Biotech said.
